Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Thyroid cancer is the most common endocrine malignancy, with papillary thyroid cancer (PTC) accounting for ∼80% of all cases. DNA methylation alterations and gene expression changes in cancer, offer valuable insights into tumor biology and serve as potential clinical biomarkers. However, the functional implications of DNA methylation changes in PTC patients, particularly based on multiomics analy...
Breast cancer (BC) is still the most diagnosed cancer for females with an increased focus on immunotherapy as a promising precise treatment. Selecting appropriate patients and monitoring patient treatments are crucial to ensure higher response rates with low adverse events. Various biomarkers were proposed to predict immunotherapy response, including tumor mutation burden, immune cell, and tumor m...
Regulated cell death (RCD) is crucial for the advancement of cancers, and providing opportunities as prognostic indicators and immunotherapy markers f...
PURPOSE: This study aimed to evaluate the image quality and clinical utility of a deep learning reconstruction (DLR) algorithm in ultra-high-resolutio...
The tumor microenvironment (TME) plays a pivotal role in tumor progression, immune evasion, and therapeutic responses. Among its key components, endot...
Senescence is a pivotal cellular process, which also plays a major role in development, immune regulation, tissue repair, and aging, triggered by stre...
OBJECTIVES: Accurate preoperative detection and analysis of lymph node metastasis (LNM) in head and neck squamous cell carcinoma (HNSCC) is essential ...
Breast cancer (BC) is a heterogeneous disease with diverse subtypes that influence prognosis and treatment outcomes. While advances have been made in ...
Flavones, recognized as "privileged scaffolds" in drug discovery, hold significant promise as anti-cancer agents. This study aimed to develop a quanti...
BCR::ABL1-targeting tyrosine kinase inhibitors (TKIs) dominate the treatment of chronic myeloid leukemia (CML) over the past decades. In this study, w...
Cancer has increasingly been recognized as a genetic disease, influenced by lifestyle changes, dietary patterns, and environmental pollutants. Lung ca...
BACKGROUND: To investigate a non-invasive radiomics-based machine learning algorithm to differentiate upper urinary tract urothelial carcinoma (UTUC) ...
BACKGROUND: Cervical cancer screening programs are increasingly relying on sensitive molecular approaches as primary tests to detect high-risk human p...
Perfluorobutanoic acid (PFBA) and perfluorobutanesulfonic acid (PFBS) are short-chain alternatives to traditional perfluoroalkyl and polyfluoroalkyl s...
Oral pathologies such as oral cancer, oral potentially malignant disorders (OPMDs), oral squamous cell carcinoma (OSCC), represent significant global ...
Immune checkpoint inhibitors (ICIs) and targeted therapies have revolutionized the management of metastatic renal cell carcinoma (mRCC). Currently, th...
Drug combination therapy is promising for cancer treatment by reducing resistance and improving efficacy. Machine learning approaches to predicting dr...
Atypia of Undetermined Significance (AUS), classified as Category III in the Bethesda Thyroid Cytopathology Reporting System, presents significant dia...
Distinguishing high-risk intraductal papillary mucinous neoplasms (IPMNs), pancreatic cysts requiring surgery, from low-risk lesions remains a clinica...
Breast cancer diagnosis heavily relies on histopathological assessment, which is prone to subjectivity and inefficiency, especially with whole-slide ...